|
SGH-200 Glycohemoglobin Analyzer – Fast and Accurate HbA1c Testing Solution
As diabetes management shifts toward point-of-care diagnostics, devices like the SGH-200 represent the kind of compact, standards-compliant hardware enabling this transition across China’s sprawling primary care network.
The SGH-200 Glycohemoglobin Analyzer is a benchtop instrument built for one specific but critical task: measuring HbA1c, the gold-standard marker for long-term blood glucose control. It processes both venous and fingertip capillary samples, requiring just 5 microliters of blood, and returns a result in under three minutes.
That speed and sample flexibility are not just convenience features. They shift the locus of testing from centralized labs to outpatient clinics and community health stations, where venous draws and batch processing were previously the only option.
The device reports results aligned with both the International Federation of Clinical Chemistry (IFCC) and the National Glycohemoglobin Standardization Program (NGSP), ensuring its outputs are compatible with global clinical guidelines and procurement requirements across different health systems.
For hospitals managing high patient volumes, the 5 μL sample requirement reduces reagent consumption over thousands of tests. The compact footprint also lowers the barrier to deployment in space-constrained facilities, which is a frequent reality in tier-2 and tier-3 city hospitals in China.
From a supply chain perspective, the SGH-200 fits into a growing category of domestic diagnostic instruments that meet international reporting standards without relying on imported consumables, a factor increasingly weighted in provincial procurement tenders.
Options for raw material sourcing and reagent cartridge integration suggest a modular approach that could allow volume-based pricing, making it viable for both public hospital tenders and private clinic networks.
The SGH-200 does not change the science of HbA1c measurement. It changes where and how often that measurement can happen—and that difference is the real product.
Why it matters:
For operators, the combination of capillary blood support and under-three-minute turnaround removes a workflow bottleneck in chronic disease management. For procurement, the dual-standard reporting and domestic supply chain alignment reduce both compliance risk and long-term consumables cost.
View Product →
|
ScientificChina — tracking China’s science, technology, and industrial systems through the lens of real-world products.
Follow ScientificChina for deeper insight into the infrastructure behind global innovation.
Visit ScientificChina.
|
|
No products in the cart.